🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate if type 2 diabetics who have inade...
Status
Completed
Location
Local Institution
Start Date
2003-10
Trial ID
NCT00240370
Treatments Being Tested
A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial ...
Status
Completed
Location
Local Institution
Start Date
2002-05
Trial ID
NCT00240383
Treatments Being Tested
This is a study to evaluate the effectiveness and tolerability of an invest...
Status
Terminated
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00130806
Treatments Being Tested
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial ...
Status
Completed
Location
Local Institution
Start Date
2003-06
Trial ID
NCT00162240
Treatments Being Tested
The purpose of this study is to compare Muraglitazar and Pioglitazone in pa...
Status
Completed
Location
Local Institution
Start Date
2005-08
Trial ID
NCT00106808
Treatments Being Tested
To determine the effect on glycemic control and lipid parameters of the 2.5...
Status
Completed
Location
Local Institution
Start Date
2003-06
Trial ID
NCT00246987
Treatments Being Tested
The purpose of this study is to learn more about how muraglitazar lowers bl...
Status
Completed
Location
Local Institution
Start Date
2004-05
Trial ID
NCT00094991
Treatments Being Tested
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial ...
Status
Completed
Location
Local Institution
Start Date
2003-07
Trial ID
NCT00162175
Treatments Being Tested
The purpose of this clinical research study is to learn whether a muraglita...
Status
Completed
Location
Local Institution
Start Date
2004-02
Trial ID
NCT00095030
Treatments Being Tested
This is a randomized, double-blind, dose-ranging, placebo-controlled trial ...
Status
Completed
Location
Local Institution
Start Date
2002-04
Trial ID
NCT00245388
Treatments Being Tested